LOGIN
Bisphosphonate treatment maintains positive effect on bone loss at 6 year follow-up
April 2013
Bisphosphonate treatment maintains positive effect on bone loss at 6 year follow-up
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty
J Orthop Res. 2009 Feb;27(2):183-8Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
49 patients who had undergone total hip arthroplasty (THA) were randomized to a postoperative bisphosphonate (oral alendronate) treatment group or to a non-treatment group, to assess the effect of bisphosphonate on bone mineral density (BMD) and bone loss. Results from this study indicated that there was a significant increase in BMD from the 1-year to the 6-year follow up in Gruen region 5 of the...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.